Artelo Biosciences (NASDAQ:ARTL) reported its Q4 earnings results on Monday, March 25, 2024 at 08:00 AM.

Here's what investors need to know about the announcement.

Earnings

Artelo Biosciences missed estimated earnings by -77.0%, reporting an EPS of $-0.99 versus an estimate of $-0.56.

Revenue was down $0 from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.18 which was followed by a 3.0% increase in the share price the next day.

** Listen to the earnings announcement yourself by clicking here. **

To track all earnings releases for Artelo Biosciences visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.